The Use of Hydroxyurea in the Treatment of COVID-19
| Autor: | Ali Atef Hijazi, Rebecca Opoku, Priya Varghese, Melissa Robin Bowman Foster, Chun Li |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Treatment protocol treatment Respiratory distress Coronavirus disease 2019 (COVID-19) RC86-88.9 business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Significant difference Medical emergencies. Critical care. Intensive care. First aid General Medicine critical respiratory care hydroxyurea covid-19 medicine Case Series Intensive care medicine business Respiratory health After treatment |
| Zdroj: | The Journal of Critical Care Medicine, Vol 7, Iss 4, Pp 312-317 (2021) The Journal of Critical Care Medicine |
| ISSN: | 2393-1817 2021-0019 |
| DOI: | 10.2478/jccm-2021-0019 |
| Popis: | Introduction The rapid worldwide spread of COVID-19 motivated medical professionals to pursue and authenticate appropriate remedies and treatment protocols. This article aims to analyze the potential benefits of one treatment protocol developed by a group of care providers caring for severe COVID-19 patients. Methods The clinical findings of COVID-19 patients who were transferred to a specialized care hospital after unsuccessful treatment in previous institutions, were analyzed. The specialized care hospital used a treatment protocol including hydroxyurea, a medication commonly used for sickle cell treatment, to improve respiratory distress in the COVID-19 patients. None of the COVID-19 patients included in the analyzed data were diagnosed with sickle cell, and none had previously taken hydroxyurea for any other conditions. Results In all presented cases, patients reverted to their baseline respiratory health after treatment with the hydroxyurea protocol. There was no significant difference in the correlation between COVID-19 and hydroxyurea. However, deaths were extremely low for those taking hydroxyurea. Conclusions Fatality numbers were extremely low for those taking hydroxyurea; death could be attributed to other underlying issues. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|